Lindsay A. Renfro

4.3k total citations
80 papers, 1.8k citations indexed

About

Lindsay A. Renfro is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Lindsay A. Renfro has authored 80 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 25 papers in Pathology and Forensic Medicine and 21 papers in Molecular Biology. Recurrent topics in Lindsay A. Renfro's work include Colorectal Cancer Treatments and Studies (27 papers), Genetic factors in colorectal cancer (19 papers) and Colorectal Cancer Surgical Treatments (17 papers). Lindsay A. Renfro is often cited by papers focused on Colorectal Cancer Treatments and Studies (27 papers), Genetic factors in colorectal cancer (19 papers) and Colorectal Cancer Surgical Treatments (17 papers). Lindsay A. Renfro collaborates with scholars based in United States, Canada and France. Lindsay A. Renfro's co-authors include Daniel J. Sargent, Sumithra J. Mandrekar, Qian Shi, Ming-Wen An, Steven R. Alberts, Leonard B. Saltz, Aimery de Gramont, Thierry André, Greg Yothers and Patricio B. Lynn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Lindsay A. Renfro

70 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lindsay A. Renfro United States	21	1.1k	450	386	349	336	80	1.8k
Lola A. Fashoyin‐Aje United States	20	1.1k 1.0×	216 0.5×	221 0.6×	450 1.3×	349 1.0×	69	1.9k
Michael H. Veeder United States	13	1.7k 1.6×	652 1.4×	488 1.3×	483 1.4×	254 0.8×	24	2.3k
Francesco Sclafani United Kingdom	24	1.2k 1.1×	326 0.7×	593 1.5×	440 1.3×	323 1.0×	121	1.9k
Fotios Siannis United Kingdom	17	659 0.6×	178 0.4×	132 0.3×	513 1.5×	252 0.8×	22	1.5k
Jean François Seitz France	18	2.8k 2.6×	974 2.2×	842 2.2×	1.0k 3.0×	379 1.1×	37	3.7k
Patricia Cortazar United States	17	872 0.8×	161 0.4×	105 0.3×	404 1.2×	402 1.2×	37	1.5k
Susanna Jacobus United States	24	1.2k 1.1×	111 0.2×	404 1.0×	431 1.2×	202 0.6×	59	2.8k
Alan Rong United States	10	850 0.8×	269 0.6×	157 0.4×	378 1.1×	166 0.5×	28	1.0k
Riccardo Capocaccia Italy	13	711 0.6×	225 0.5×	209 0.5×	366 1.0×	217 0.6×	23	1.4k
G. Pentheroudakis Greece	14	1.3k 1.2×	124 0.3×	331 0.9×	411 1.2×	384 1.1×	33	2.2k

Countries citing papers authored by Lindsay A. Renfro

Since Specialization

Citations

This map shows the geographic impact of Lindsay A. Renfro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsay A. Renfro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsay A. Renfro more than expected).

Fields of papers citing papers by Lindsay A. Renfro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsay A. Renfro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsay A. Renfro. The network helps show where Lindsay A. Renfro may publish in the future.

Co-authorship network of co-authors of Lindsay A. Renfro

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsay A. Renfro. A scholar is included among the top collaborators of Lindsay A. Renfro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsay A. Renfro. Lindsay A. Renfro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armstrong, Amy E., Najat C. Daw, Lindsay A. Renfro, et al.. (2025). Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies. Cancer. 131(2). e35713–e35713. 2 indexed citations

Benedetti, Daniel J., Nicholas G. Cost, Peter F. Ehrlich, et al.. (2025). Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials. Nature Reviews Urology. 22(11). 775–788.

Greenzang, Katie A., Kathleen Montgomery, Adam DuVall, et al.. (2025). Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination. JNCI Journal of the National Cancer Institute. 117(9). 1764–1773.

Zheng, Daniel J., Angie Mae Rodday, Sharon M. Castellino, et al.. (2025). Caregiver At‐Work Productivity Loss at the Time of a Child's Diagnosis With High‐Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD1331 Study. Pediatric Blood & Cancer. 72(9). e31841–e31841.

Marks, Lianna J., Yue Wu, Kathleen M. McCarten, et al.. (2025). PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1. Pediatric Blood & Cancer. 72(5). e31606–e31606. 1 indexed citations

Renfro, Lindsay A., et al.. (2024). Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Sub-Study of Children’s Oncology Group AHOD 0431. International Journal of Radiation Oncology*Biology*Physics. 120(2). S91–S91.

Benedetti, Daniel J., Lindsay A. Renfro, Najat C. Daw, et al.. (2024). Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Cancer. 130(13). 2361–2371. 2 indexed citations

Murphy, Andrew J., Jack Brzezinski, Lindsay A. Renfro, et al.. (2024). Long‐term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study. International Journal of Cancer. 155(10). 1824–1831. 3 indexed citations

Heneghan, Mallorie B., Susan K. Parsons, Frank G. Keller, et al.. (2024). Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma. JCO Oncology Practice. 21(4). 526–534. 3 indexed citations

10.

Goldstein, Jeffrey A., Lindsay A. Renfro, Lawrence J. Jennings, et al.. (2023). BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children’s Oncology Group Study AREN03B2. Archives of Pathology & Laboratory Medicine. 148(10). e362–e366. 1 indexed citations

11.

Benedetti, Daniel J., Carly R. Varela, Lindsay A. Renfro, et al.. (2023). Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5. Cancer. 130(6). 947–961. 3 indexed citations

12.

Geller, James I., Andrew L. Hong, Kelly Vallance, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Renal tumors. Pediatric Blood & Cancer. 70(S6). e30586–e30586. 11 indexed citations

13.

Evageliou, Nicholas F., Lindsay A. Renfro, James I. Geller, et al.. (2023). Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532. Cancer. 130(5). 792–802. 3 indexed citations

14.

Oosterom, Natanja, Saskia L. Gooskens, Lindsay A. Renfro, et al.. (2023). Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy. Journal of Clinical Oncology. 41(26). 4247–4256. 1 indexed citations

15.

Madanat‐Harjuoja, Laura, Lindsay A. Renfro, Kelly Klega, et al.. (2022). Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. Journal of Clinical Oncology. 40(26). 3047–3056. 18 indexed citations

16.

Borad, Mitesh J., Lindsay A. Renfro, Nathan R. Foster, et al.. (2016). P-100 Phase IB study of sorafenib + evofosfamide in patients (pts) with advanced hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC): NCCTG N1153 (Alliance). Annals of Oncology. 27. ii29–ii29. 1 indexed citations

17.

Foster, Nathan R., Lindsay A. Renfro, Steven E. Schild, et al.. (2015). Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(7). 1099–1106. 33 indexed citations

18.

Renfro, Lindsay A., Axel Grothey, James Paul, et al.. (2014). Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting Analysis Dates for the IDEA Collaboration. SHILAP Revista de lepidopterología. 5(2). 1–7. 1 indexed citations

19.

Shiovitz, Stacey, Monica M. Bertagnolli, Lindsay A. Renfro, et al.. (2014). CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer. Gastroenterology. 147(3). 637–645. 104 indexed citations

20.

Lieu, Christopher H., Lindsay A. Renfro, Aimery de Gramont, et al.. (2013). The impact of young age on survival in patients with metastatic colorectal cancer: Analysis from the ARCAD Clinical Trials Program. European Journal of Cancer. 49. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact